As of Nov 19, 2026, 1 of 1 active firms rate CLPT a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CLPT EPS & revenue forecast
EPS · NEXT QUARTER
$-0.23
Range $-0.24 – $-0.23 · 2 analysts · -27% YoY
Next period, 2 analysts expect Clearpoint Neuro Inc to earn $-0.23 a share (range $-0.24 – $-0.23), versus $-0.32 a year earlier. Full-year consensus is $-1.17, growing to $-0.92 the year after.
REVENUE · NEXT QUARTER
$13.2M
Range $12.9M – $13.5M · 2 analysts · +9% YoY
Revenue is expected to reach $13.2M (range $12.9M – $13.5M), +8.8% year-over-year. Full-year consensus is $48.5M, rising to $55.8M next year.
Top analysts covering Clearpoint Neuro Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLPT.
#1
Frank Takkinen
Lake Street · Rank #514
Buy
$30.00+289.6% to target
Overall win rate
27%
+ Follow
#2
NC
Neil Chatterji
B. Riley Securities
Buy
$20.00+159.7% to target
Coverage
—
+ Follow
#3
AS
Anderson Schock
B. Riley Securities
Buy
$30.00+289.6% to target
Coverage
—
+ Follow
#4
MB
Mathew Blackman
Stifel
Buy
$25.00+224.7% to target
Coverage
—
+ Follow
CLPT stock forecast FAQ
What is CLPT's average 12-month price target?+
The 1 active firms with a live target average $30.00 for Clearpoint Neuro Inc over the next 12 months, ranging from a $30.00 high to a $30.00 low, as of Nov 19, 2026.
Is CLPT stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover CLPT?+
1 active firms have a recognized rating on Clearpoint Neuro Inc as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CLPT?+
Among analysts who currently cover CLPT, Frank Takkinen of Lake Street has the strongest overall Quantellect track record (Rank #514). Their current call is Buy with a $30.00 target.
What is Clearpoint Neuro Inc's projected EPS for next quarter?+
The consensus estimate is $-0.23 per share (range $-0.24 – $-0.23) across 2 analysts. Full-year EPS is projected at $-1.17, rising to $-0.92 the following year.
How much revenue is Clearpoint Neuro Inc expected to report next quarter?+
Consensus revenue is $13.2M (range $12.9M – $13.5M). Full-year revenue is projected at $48.5M, growing to $55.8M next year.
Have analysts been upgrading or downgrading CLPT lately?+
As of Nov 19, 2026, 1 of 1 active firms rate CLPT a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLPT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.